
MarvelBiome: A biopharmaceutical company harnessing microbial power for innovative disease treatments.
MarvelBiome is a biopharmaceutical company founded with the mission of harnessing the power of microbes to treat various human diseases. The company focuses on isolating, identifying, and characterizing microbial populations to develop novel therapeutic applications. By leveraging the therapeutic potential of the microbiome, MarvelBiome aims to revolutionize disease treatment and improve overall wellness.
The co-founders of MarvelBiome are dedicated researchers in the field of microbiome science. The company has garnered attention for its innovative approach and has attracted notable investors in the biopharmaceutical sector. MarvelBiome's key achievements include significant advancements in microbial therapy research, positioning it as a leader in the industry. Its impact lies in pioneering new treatments that could transform healthcare by utilizing the natural capabilities of microbes.

Petri Bio
petribio.com

Microbiome Therapeutics

Naked Biome

GenieBiome

Holobiome
holobiome.org

Federation Bio
federation.bio

DermBiont
dermbiont.com

Biomiic

Microbion
microbioncorp.com

BiomeSense
biomesense.com

BrilliantBiome
brilliantbiome.com

MatriSys Bioscience
matrisysbio.com

PhagePro
phageproinc.com

BlueTurtleBio Technologies
blueturtlebio.com

BioPlx
Companies similar to MarvelBiome include Petri Bio, Microbiome Therapeutics, Naked Biome and GenieBiome.
MarvelBiome was founded in 2019.
MarvelBiome's headquarters is located in Woburn, MA, US.
MarvelBiome's most recent funding round was for $3.1M (USD) in November 2020.
As of Nov 17, 2020, MarvelBiome has raised a total of $3.1M (USD).
MarvelBiome has 9 employees as of Feb 5, 2024.